Home/Filings/4/0001214659-19-005969
4//SEC Filing

Marshall Ken W. 4

Accession 0001214659-19-005969

CIK 0001398733other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 4:30 PM ET

Size

6.3 KB

Accession

0001214659-19-005969

Insider Transaction Report

Form 4
Period: 2019-09-18
Marshall Ken W.
Commercial Leader
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-09-18+66,00066,000 total
    Exercise: $3.49Exp: 2029-09-18Common Stock (66,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,445
Footnotes (2)
  • [F1]Shares held by the Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall.
  • [F2]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001740092

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:30 PM ET
Size
6.3 KB